Medical Research News

RSS

Alcohol consumption increases risk of several cancers while coffee protects against liver, skin cancer

Alcohol consumption is a major risk factor for several cancers including head & neck, oesophageal and bowel cancer – as well as the more widely known links to breast and liver cancer – according to a new study funded by World Cancer Research Fund, and published this week in Nature Communications.

11 Aug 2021

Analysis finds stable or decreasing trends in cervical cancer incidence and mortality

A recent trend analysis indicates that cervical cancer incidence and mortality rates have remained stable or are dropping in most countries across the globe.

11 Aug 2021

Emerging biosensing technologies could revolutionize the diagnosis of neonatal sepsis

Sepsis in newborn infants can be fatal. Early diagnosis is thus key to effectively manage the infection. Conventional diagnostic methods are, however, time-consuming.

11 Aug 2021

Study finds high risk groups rejecting the COVID-19 vaccine in England

To increase COVID-19 vaccination rates, public health officials must understand who is refusing the vaccines. New research led by Ben Goldacre from the University of Oxford found that about 2% of people considered high-risk did not want the vaccine when offered. In addition, vaccination refusal in priority groups was most common among English people who are Black, South Asian, or from lower socioeconomic areas.

11 Aug 2021

Math and language processed by separate networks in the brain, reveals research

Separate math and language networks segregate naturally when listeners pay attention to one type over the other, according to research recently published in JNeurosci.

11 Aug 2021

Knowing genetic risk for breast cancer leads to fewer regrets

Women who found out their genetic risk for breast cancer had fewer regrets than those who opted not to find out.

11 Aug 2021

In Australia, high vaccine hesitancy among most vulnerable to COVID-19

World Health Organization (WHO) guidelines indicate the optimal timing of vaccination among specific groups based on the probability of infection and transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), e.g., health care workers providing direct care or acute disease and death (e.g., older people, organ transplant recipients).

11 Aug 2021

A new promising target for broad-spectrum therapeutics against coronaviruses

A recent study by Canadian and US researchers demonstrates how frameshift signals of coronaviruses represent a viable target for developing novel therapeutics with broad-spectrum activity – not only against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other constituents of the coronavirus family. The study is currently available on the bioRxiv* preprint server while it undergoes peer review.

11 Aug 2021

Researchers employ artificial intelligence models for image-based detection of COVID-19

Medical imaging has long been a vital tool for the diagnosis and prognostic assessments of many diseases. In recent years, the use of artificial intelligence models has been used in conjunction with this imaging to augment their diagnostic capabilities.

11 Aug 2021

COVID-19 vaccines offer better protection than natural immunity alone

Now, the U.S. Centers for Disease Control and Prevention (CDC) reports that among people who were previously infected with SARS-CoV-2, those who were still unvaccinated are more likely to be reinfected than those fully vaccinated after prior infection.

11 Aug 2021

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Scientists from Germany and Belgium have recently described the immunogenicity of a plant-based virus-like particle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine induces robust antibody and T cell responses for at least 6 months. Moreover, the vaccine demonstrates potent neutralizing efficacy against the B.1.1.7, B.1.351, and P1 variants of SARS-CoV-2.

11 Aug 2021

Both mRNA vaccines protect against symptomatic disease with SARS-CoV-2 Delta variant

A new study demonstrates that the two mRNA vaccines have widely varying efficacies against the SARS-CoV-2 Delta variant.

10 Aug 2021

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

A new study explores the polyclonal antibody response to SARS-CoV-2 in greater detail.

10 Aug 2021

Green spaces, especially forest, reduce COVID-19 incidence, study says

An intriguing new study reveals that the closer you are to green spaces, especially forests, the less likely you are to be infected with SARS-CoV-2.

10 Aug 2021

Study shows efficacy of gamma irradiation of SARS-CoV-2 vaccine candidate in mouse model

A new study reports a more rapid method of viral inactivation in an effort to increase the appeal of inactivated viral vaccines against the COVID-19 pandemic.

10 Aug 2021

High alcohol consumption increases risk of SARS-CoV-2 infection, finds US student study

A new study finds that heavy alcohol drinking is associated with an increase in the number of COVID-19 cases among American college students.

10 Aug 2021

Natural vs. vaccine-induced COVID-19 immunity

A new paper discusses the protection offered by immunity against COVID-19 following vaccination as compared to natural infection.

10 Aug 2021

Hypoxic inflammation leads to inefficient cardiac repair after heart attacks

Activation of hypoxia inducible factors (green) in macrophages (purple) that have infiltrated damaged cardiac tissue (right) in heart tissue.

10 Aug 2021

Researchers develop method to attach biosensors to human skin without an adhesive

Imagine if you could attach something to your skin without needing glue. A biosensor, a watch, a communications device, a fashion accessory - the possibilities are endless.

10 Aug 2021

Study identifies Foxo1 gene as a potential treatment target for hereditary lymphedema

A University of South Florida preclinical study unexpectedly identified the gene Foxo1 as a potential treatment target for hereditary lymphedema.

10 Aug 2021

Medical Research News

Alcohol consumption increases risk of several cancers while coffee protects against liver, skin cancer

Analysis finds stable or decreasing trends in cervical cancer incidence and mortality

Emerging biosensing technologies could revolutionize the diagnosis of neonatal sepsis

Study finds high risk groups rejecting the COVID-19 vaccine in England

Math and language processed by separate networks in the brain, reveals research

Knowing genetic risk for breast cancer leads to fewer regrets

In Australia, high vaccine hesitancy among most vulnerable to COVID-19

A new promising target for broad-spectrum therapeutics against coronaviruses

Researchers employ artificial intelligence models for image-based detection of COVID-19

COVID-19 vaccines offer better protection than natural immunity alone

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Both mRNA vaccines protect against symptomatic disease with SARS-CoV-2 Delta variant

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

Green spaces, especially forest, reduce COVID-19 incidence, study says

Study shows efficacy of gamma irradiation of SARS-CoV-2 vaccine candidate in mouse model

High alcohol consumption increases risk of SARS-CoV-2 infection, finds US student study

Natural vs. vaccine-induced COVID-19 immunity

Hypoxic inflammation leads to inefficient cardiac repair after heart attacks

Researchers develop method to attach biosensors to human skin without an adhesive

Study identifies Foxo1 gene as a potential treatment target for hereditary lymphedema

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News